| mRNA |
ML312 |
CTRPv2 |
pan-cancer |
AAC |
0.42 |
3e-10 |
| mRNA |
BRD-K34099515 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
2e-05 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.001 |
| mRNA |
QL-VIII-58 |
GDSC1000 |
pan-cancer |
AAC |
0.15 |
0.002 |
| mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.15 |
0.004 |
| mRNA |
ZG-10 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.009 |
| mRNA |
Vorinostat |
FIMM |
pan-cancer |
AAC |
-0.36 |
0.02 |
| mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.02 |
| mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.078 |
0.02 |
| mRNA |
SR8278 |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
0.02 |